Detalhe da pesquisa
1.
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
Haematologica
; 109(1): 115-128, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199127
2.
Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry.
Haematologica
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634126
3.
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.
Am J Hematol
; 99(4): 586-595, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317420
4.
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia.
Blood
; 137(14): 1879-1894, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150388
5.
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
Haematologica
; 108(4): 969-980, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325893
6.
Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse.
Haematologica
; 106(9): 2325-2333, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732356
7.
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Haematologica
; 106(12): 3079-3089, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179471
8.
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Hematol Oncol
; 39(4): 529-538, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405901
9.
Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity.
Br J Haematol
; 189(4): 672-683, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068246
10.
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia.
Haematologica
; 104(2): 288-296, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30093399
11.
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.
Eur J Haematol
; 102(1): 79-86, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30267597
12.
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure.
Biol Blood Marrow Transplant
; 23(10): 1631-1640, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533060
13.
Fatal graft-versus-host disease after allogeneic stem cell transplantation in a patient recently exposed to nivolumab.
J Oncol Pharm Pract
; : 1078155217743069, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29207936
14.
Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study.
Br J Haematol
; 163(5): 581-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24117042
15.
First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group.
Haematologica
; 98(10): 1563-70, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23753021
16.
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment.
Hematol Oncol
; 36(5): 765-772, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30129233
17.
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
Blood Cancer J
; 13(1): 77, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173322
18.
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
Cancers (Basel)
; 15(2)2023 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36672386
19.
Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.
Am J Hematol
; 87(6): 631-4, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22431002
20.
Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries.
Leukemia
; 36(4): 913-922, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775483